期刊文献+

聚乙二醇醛(mPEG-ALD_(20000))对L-门冬酰胺酶化学修饰的初步研究 被引量:3

Primary Study on the Modification of L-ASP with mPEG-ALD_(20000)
原文传递
导出
摘要 研究L-门冬酰胺酶的单甲氧基聚乙二醇醛化学修饰及纯化方法。以SDS-PAGE分析产物的单修饰产率,对反应的摩尔比,反应的pH值和反应时间和温度修饰条件进行优化,初步确定最佳修饰条件为L-ASP与mPEG、ALD反应摩尔比是1∶10,反应pH值为5.0,在4℃下反应32 h。离子交换和分子筛联用对产物进行分离纯化,修饰产物活性残留达36%。修饰产物结构没有明显变化,活性得到很好的保留。 L-asparaginase (L-ASP) modified with succinimidehyde monomethoxy polyethylene glycol (mPEG-ALD) and its purification was studied. The modification rate of mono-PEGylated enzyme by SDS-PAGE was analyzed and the modified conditions, such as molecular ratio, pH value, reaction tem- perature and time were optimized. The optimized reaction conditions were found to be phosphate buffer pHS. 0,moleeuar ratio of mPEG-ALD to L-ASP 10 : 1, reaction time 32h and reaction temperature 4℃. The PEGylated enzyme was purified by anion-exchange and gel filtration and its activity retained 360%. The modified PEG-L-ASP with noob change in strueture and its activity has been well reserved.
出处 《药物生物技术》 CAS CSCD 2009年第3期212-216,共5页 Pharmaceutical Biotechnology
基金 校内药物传递系统技术平台项目(35210514)
关键词 L-门冬酰胺酶 聚乙二醇醛 化学修饰 分离纯化 L - asparaginase, mPEG-ALD, Chemical modification, Isolation and purification
  • 相关文献

参考文献12

  • 1Fabry U, Korholz D, Jurgens H, et al. Anahylaxis to L - Asparaginase during treatment for acutement mediated mechanism[J]. Pediatr Res, 1985, 19(4) :400.
  • 2] Keating M J, Holmes R, Lerner S, et al. L - asparaginase and PEG asparaginase: past, present, and future [J]. Leuk Lymphoma, 1993, 10..153.
  • 3Matsushima A, Nishimura H, Ashihara Y, et al. Modifica tion of E. coli asparaginase with 2,4-bis(O-methoxy-polyeth ylene glyeol)-6-chloro-S-triazine disapperance of binding abil ity towards anti-serum and retention of enzymic activity[J]. Chem Letter, 1980, 9(7):773.
  • 4史凌洋,魏东芝.用活化的单甲氧基聚乙二醇修饰L-天冬酰胺酶[J].华东理工大学学报(自然科学版),2001,27(6):601-604. 被引量:6
  • 5杨宇峰,黄静,徐帆洪,吴腾捷,吴自荣,楼觉人.聚乙二醇修饰重组人干扰素-α1b条件的优化[J].中国生物制品学杂志,2008,21(4):329-332. 被引量:5
  • 6Lee H, Jang I H, Ryu S H, et al. N-terminal site-specific mono-PEGylation[of epidermal growth factor [J]. Pharm Res, 2003, 20(5) :818.
  • 7韦玉军,陈建华,吴梧桐.E.coli L-天冬酰胺酶结构与功能及其纯化工艺[J].药学进展,2005,29(9):397-404. 被引量:5
  • 8Caliceti P. Pharmacokinetics of pegylated inteferons: what is misleading[J].Dig Liver Dis, 2004, 36(3) : 334.
  • 9朱珺,王松梅,沈炜明,吴自荣,刘银坤.抗肿瘤转移多聚β肽聚乙二醇化的研究[J].中国新药与临床杂志,2005,24(9):723-726. 被引量:6
  • 10Caliceti P, Veronese F M. Pharmacokinetic and biodistribution properties of poly (ethylene glycol)-protein conjugates [J]. Adv Dru Deiv Rev, 2003, 55(10) : 1 261.

二级参考文献48

  • 1戚洪渊,王建学.柱层析法提取门冬酰胺酶[J].齐鲁药事,2004,23(6):57-58. 被引量:1
  • 2王松梅,朱珺,李岩,潘銮凤,查锡良,刘银坤.新型三聚β肽对人肝癌细胞系迁移和侵袭能力的影响[J].中华肝脏病杂志,2005,13(7):541-542. 被引量:2
  • 3刘景晶,李晶,吴梧桐,胡梅清.大肠杆菌L-天门冬酰胺酶Ⅱ基因的高效表达[J].中国药科大学学报,1996,27(11):696-700. 被引量:19
  • 4张树政,酶制剂工业.下,1984年,709页
  • 5徐宜为,试验免疫学技术,1979年,18页
  • 6Iiboshi Y, Papst P J, Terada N, et al. L-asparaginase in-hibits the Rapamycin-targeted signaling pathway[J].Biochem Biophys Res Commun, 1999, 260 (2): 534-539.
  • 7Dübbers A, Würthwein G, Müller H J. Asparaginase synthe tase activity in paediatric acute leukaemias[J].Br J Haematol, 2000, 109(2): 247-252.
  • 8Jaskólski M, Borek D. Sequence analysis of enzymes with asparaginase activity[J]. Acta Biochimica Polonica, 2001, 48(4): 893-902.
  • 9Graham M L. Pegaspargase: a review of clinical studies[J]. Adv Drug Deliv Rev, 2003,55 (10): 1293-1302.
  • 10Quin M J, Zhao F S. L-Asparaginase release from Esche-richia coli cells with aqueous two-phase micellar systems[J]. Appl Biochem Biotechol, 2003,110 (1): 11-21.

共引文献17

同被引文献50

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部